APONTIS PHARMA starts financial year 2024 with growth in revenue of Single Pill combinations and positive net result – forecast for full-year 2024 confirmed
EQS Group
EQS-News: APONTIS PHARMA AG / Key word(s): Quarterly / Interim Statement/Quarter Results
APONTIS PHARMA starts financial year..